cyclopentane has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Barroso de Oliveira, AS; Coelho, F; Costa-Lotufo, LV; da Silva, JCL; Dos Santos, RN; Fernandes, DC; Gomes, RDC; Lima, K; Machado-Neto, JA; Rodrigues Junior, MT; Vicari, HP | 1 |
1 other study(ies) available for cyclopentane and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; DNA Damage; Drug Resistance, Neoplasm; Humans; Indoles; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Models, Molecular; Stathmin; Tumor Stem Cell Assay | 2021 |